Regentis Biomaterials Ltd. (RGNT) — Financial Flexibility Index
Regentis Biomaterials Ltd. (RGNT) has a Financial Flexibility Index of -0.48x as of December 2025. Free cash flow of $-1.38 Million (operating CF $-1.38 Million minus capex $0.00) represents 0% of total liabilities ($2.87 Million). For the full cash flow conversion analysis, see Regentis Biomaterials Ltd. cash conversion from operations.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Regentis Biomaterials Ltd. Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Regentis Biomaterials Ltd. across 4 annual periods. Check tangible equity quality of Regentis Biomaterials Ltd. to evaluate the tangible quality of the company's equity base.
Annual Financial Flexibility Index for Regentis Biomaterials Ltd. (2022–2025)
Year-by-year free cash flow to debt coverage for Regentis Biomaterials Ltd.. Explore how well can Regentis Biomaterials Ltd. service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.48x | $-1.38 Million | $-1.38 Million | $2.87 Million | ▼ -3003.9% |
| 2024 | -0.02x | $-641.00K | $-641.00K | $41.59 Million | ▲ +41.5% |
| 2023 | -0.03x | $-1.22 Million | $-1.22 Million | $46.27 Million | ▲ +23.2% |
| 2022 | -0.03x | $-1.50 Million | $-1.50 Million | $43.78 Million | — |